Clinical Trial Update: Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reporting completed Phase 1/2 studies of hydroxytriptolide in active rheumatoid arthritis patients who did not respond adequately to met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Hydroxytriptolide (hydroxytriptolide)

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED